NASDAQ:VRAY
Delisted

Viewray Stock Predictions

etoro logo Buy VRAY
*Your capital is at risk
$0.0250
+0 (+0%)
At Close: Nov 20, 2023
Currently predicting for Mon, 8 Jun 2026

VRAY Prediction Chart

VRAY Predictions History

Latest community submissions for VRAY.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jun 10, 2021 $6.06 +5.21% $5.76 X 94.79% 0
Jun 10, 2021 Bullish $5.76 X 0
JS JS Pro
Jun 8, 2021 $6.71 +9.64% $6.12 X 90.36% 0
Jun 8, 2021 $20.00 +226.80% Unrealistic Excluded from avg $6.12 X 0.00% 0
JS JS Pro
Apr 15, 2021 $4.38 -1.35% $4.44 X 98.65% 1
Andrea Winder Andrea Winder @AndreaWinder.174444
Apr 15, 2021 Bullish $4.44 X 1
Max Glater Max Glater @MaxGlater.182088
Apr 15, 2021 $20.00 +350.45% Unrealistic Excluded from avg $4.44 X 0.00% 1
JS JS Pro
Dec 22, 2020 $4.04 +1.51% $3.98 X 98.49% 1
JS JS Pro
Dec 18, 2020 $4.04 -1.58% $4.11 X 98.42% 1
May 7, 2019 $7.94 -1.14% $8.03 X 98.86% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VRAY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIEWRAY INC
ViewRay
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hos...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE